Monoclonal Antibodies

More Treatment Topics

Chemotherapy | Immunotherapy | Radiotherapy | Treatment

The monoclonal antibody Rituxan (rituximab),

The results of a pair of long-term survival studies indicate the therapeutic value of

In case you're unfamiliar, the Rituxan Retirement Plan (RRP) is an inside joke amongst

Bexxar® (tositumomab and iodine I 131 ) is a radiolabled

Monoclonal Antibody (mAB) Therapy is a type of

Oncolym (131I Lym-1) is an Iodine 131 radiolabled

FDA Approves the Removal of the Bioscan Requirement for ZEVALIN® Treatment


Rituxan (rituximab), the anti-CD20 monoclonal antibody from Roche, has carried the market since

Rituxan® is the brand marketing name of the monoclonal

According to research presented at the annual meeting of the American Society of Hematology,

Today the US Food and Drug Administration granted accelerated approval for Darzalex (

At the 17th Congress of the European Hematology Association (EHA), biopharmaceutical company

Spectrum Pharmaceuticals will be presenting five study abstracts related to Zevalin, the company